Vale
building a robust project portfolio eta | Vale
Company
Deck Type
Sector
Industry
Deck date
February 2022
Slide
12 of 20
Related slides by other companies
NW Natural Holdings
Investor Conference
May 2020
deep decarbonization | NW Natural Holdings
Chimerix
Investor Presentation
August 2023
agonist distinct molecular target and efficacy profile relative to efficacy in preclinical models of advanced cancers tox studies complete potential to advance to partnerships established for early stage clinical trials with brown university and cancer center preclinical studies are ongoing to evaluate additional oncology indications and predictive for for clinical development pancreatic cancer model shows the potential of | Chimerix
Alkermes
Investor Conference
January 2022
first in human study underway and clinical strategy focused on early validation of biology | Alkermes
NW Natural Holdings
Investor Presentation
March 2020
deep decarbonization | NW Natural Holdings
Other recent decks by Vale
See all presentations (20 decks)
Results
July 2022
Investor Conference
May 2022
Results
April 2022
Investor Presentation
April 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights